NYPOZI txid
Filgrastim-txid · Tanvex BioPharma USA, Inc.
PRESCRIPTION ONLY (USA)NYPOZI txid ingredients
| Active ingredient | Strength |
|---|---|
| Filgrastim | 300 ug/300ug, 480 ug/480ug |
What NYPOZI txid is used for
NYPOZI txid is a specialist medicine (leukocyte growth factor). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- NYPOZI txid
- Generic name
- Filgrastim-txid
- Made by
- Tanvex BioPharma USA, Inc.
- Forms
- Injection
- Given
- Intravenous, Subcutaneous
- Drug class
- Leukocyte Growth Factor
- FDA approval
- Biologic licence (BLA) BLA761126
- On the US market since
- 2025
Official information
- NYPOZI txid prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Filgrastim-txid)
In India
- Filgrastim: 30 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is NYPOZI txid?
NYPOZI txid (Filgrastim-txid) is a specialist medicine made by Tanvex BioPharma USA, Inc., approved by the US FDA.
What are the ingredients of NYPOZI txid?
NYPOZI txid contains Filgrastim (300 ug/300ug, 480 ug/480ug).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA